|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01255 TATA HEALTH
Nominal 
0.300 0.000 (0.000%) | 2023/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 104,131 | 63.945% | 144,606 | 160,925 | 155,363 | 341,773 |
| Cost of Sales | (18,898) | 72.317% | (30,662) | (56,207) | (121,080) | (142,300) |
| Gross Profit | 85,233 | 62.197% | 113,944 | 104,718 | 34,283 | 199,473 |
| 2023/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | (3,937) | |
| Change in FV & Impairment on Others | -- | -- | (1,452) | (9,709) | (38,541) | (27,280) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | (400) | (573) | 780 | 0 | |
| Profit / (Loss) before Taxation | (14,290) | -- | 4,104 | (69,143) | (172,683) | (67,446) | |
| Taxation | 0 | -- | (898) | (1,311) | (396) | 544 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 1,963 | -43.315% | 6,407 | 9,693 | 21,210 | 5,977 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (12,327) | -- | 9,613 | (60,761) | (151,869) | (60,925) | |
| 2023/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | 392 | -2.244% | 1,049 | 1,568 | 3,007 | 2,559 |
| Depreciation & Amortisation | 6,042 | 0.851% | 12,017 | 13,763 | 24,414 | 32,324 |
| Directors' Emoluments | -- | -- | 8,624 | 9,507 | 10,218 | 5,757 |
| 2023/06 - Interim | %Chg (Compare to Interim) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified |
Market Valuation Indicators
| 2023/06 - Interim | %Chg (Compare to Interim) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -5.000 | -- | 4.000 | -26.000 | -71.000 | -28.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.054 | (0.021) | 0.001 | 0.077 |
| NBV per share ($) | 0.093 | -- | 0.139 | 0.095 | 0.047 | 0.751 |
| Remarks: | Real time quote last updated: 25/11/2024 09:35 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -12,327,000 |
| %Change | -- |
| EPS / (LPS) | HKD -0.050 |
| NBV Per Share ($) | HKD 0.093 |